Infections as complications of neuroleptic malignant syndrome

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 3, 2009, Pages 973-976

  Bilanakis, Nikolaos ^a   Peritogiannis, Vaios ^a   Kalampokis, Georgios ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Bronchitis; Complication; Infection; Neuroleptic malignant syndrome; Urinary tract infection

Indexed keywords

CEFUROXIME AXETIL; DIAZEPAM; HALOPERIDOL; LITHIUM; ANTIINFECTIVE AGENT; CEFUROXIME; DRUG DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; CASE REPORT; DEEP VEIN THROMBOSIS; HUMAN; INFECTION; KIDNEY FAILURE; LABORATORY TEST; LUNG EMBOLISM; MALE; MANIA; NEUROLEPTIC MALIGNANT SYNDROME; PARANOID SCHIZOPHRENIA; ACUTE KIDNEY FAILURE; ADOLESCENT; DEHYDRATION; FEMALE; FLUID THERAPY; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIPSYCHOTIC AGENTS; CEFUROXIME; DEHYDRATION; FEMALE; FLUID THERAPY; HUMANS; KIDNEY FAILURE, ACUTE; MALE; NEUROLEPTIC MALIGNANT SYNDROME; RESPIRATORY TRACT INFECTIONS;

EID: 77949521079     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970801935578     Document Type: Article

References (25)

1. Addonizio G, Susman VL, Roth SD. 1987. Neuroleptic malignant syndrome: Review and analysis of 115 Cases. Biol Psychiatry 22:1004-1020.
2. Adnet P, Lestavel P, Krivosic-Horber R. 2000. Neuroleptic malignant syndrome. Br J Anaesth 85:129-135.
3. Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sindhom T. 2004. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 65:464-470
4. Beaujean DJ, Blok HE, Vandenbroucke-Grauls CM, Weersink AJ, Raymakers JA, Verhoef J. 1997. Surveillance of nosocomial infections in geriatric patients. J Hosp Infect 36:275-284.
5. Chamorro A, Urra X, Planas A. 2007. Infection after acute ischemic stroke: a manifestation of brain-induced immunode-pression. Stroke 38:1097-1103.
6. Choi-Kain L, Pope H. 2007. "Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes. Harv Rev Psychiatry 15:181-186.
7. Gurrera R. 1999. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry 156:169-180.
8. Guze BH, Baxter L Jr. 1985. Current concepts: Neuroleptic malignant syndrome. New Engl J Med 313:163-166.
9. Kaufmann CA, Wyatt RJ. Neuroleptic malignant syndrome. 1987. In: Meltzer H, editor. Psychopharmacology: The third generation of progress. New York: Raven.
10. Lazarus A. 1990. Should neuroleptic malignant syndrome be treated in a private psychiatric hospital or a general hospital? Gen Hosp Psychiatry 12:245-247.
11. Lenz A, Franklin G, Cheadle W. 2007. Systemic inflammation after trauma. Injury 38:1336-1345.
12. Levenson JL. 1985. Neuroleptic malignant syndrome. Am J Psychiatry 142:1137-1145.
13. Liam CK, Ong SBY. 1990. Neuroleptic malignant syndrome with renal and respiratory complications: a case report. Sing Med J 31:182-184.
14. Muhammed K, Raman P. 2005. Simultaneus occurrence of toxic epidermal necrolysis and neuroleptic malignant syndrome. Indian J Dermatol Venereol Leprol 71:270-272.
15. Patel U, Argawal M, Krishnan P, Niranjan S. 2002. Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea. J. Natl Med Assoc 94:279-282.
16. Pelonero AL, Levenson JL, Pandurangi AK. 1998. Neuroleptic malignant syndrome: a review. Psychiatr Serv 49:1163-1172.
17. Reulbach U, Dutsch C, Biermann T, Sperling W, Thuerauf N, Kornhuber J, et al. 2007. Managing an effective treatment for neuroleptic malignant syndrome. Crit Care 11:R4.
18. Rubin B. 2002. Physiology of airway mucus clearance. Respir Care 47:761-768.
19. Sachdev P. 2005. Neuroleptic-induced movement disorders: an overview. Psychiatr Clin North Am 28:255-274.
20. Schwacha M, Chaudry I. 2002. The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med 10:239-243.
21. Sherman CB, Hashimoto F, Davidson EJ. 1983. Gas-producing escherichia coli fasciitis in a patient with the neuroleptic malignant syndrome. J Am Med Assoc 250:361.
22. Smith JA, Carter GH. 1984. Neuroleptic malignant syndrome with a positive Weil-Felix test. Am J Psychiatry 141:609.
23. Still J, Friedman B, Law E, et al. 1998. Neuroleptic malignant syndrome in a burn patient. Burns 24:573-575.
24. Srawn J, Keck P, Caroff S. 2007. Neuroleptic malignant syndrome. Am J Psychiatry 164:870-876.
25. Teglia MQ, Hopkins TT, Cunha BA. 1991. Neuroleptic malignant syndrome and Escherichia coli urosepsis. Heart Lung 20:202-205.